Kunming CR Torch

Kunming CR Torch Pharmaceutical, a subsidiary of China Resources Sanjiu (CR Sanjiu), is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacturing of cardiovascular and cerebrovascular medicines. The company is best known for its flagship product, Xuesaitong Soft Capsules, which are derived from Panax notoginseng saponins and widely used in China for treating stroke and coronary heart disease. Kunming CR Torch operates as a key high-tech enterprise within the Yunnan province, leveraging local botanical resources to produce high-quality Traditional Chinese Medicine (TCM) and modern natural drug formulations. Since its acquisition by CR Sanjiu in 2016, the company has integrated into the broader China Resources healthcare ecosystem, focusing on expanding its market leadership in the blood-activating and stasis-resolving therapeutic segment. Its operations include large-scale GMP-certified manufacturing facilities and a dedicated R&D center focused on natural medicine innovation.